7 Related NICE guidance

7 Related NICE guidance

Published

Patient experience in adult NHS services. NICE clinical guidance 138 (2012)

Hepatitis C (genotype 1) – boceprevir. NICE technology appraisal 253 (2012)

Hepatitis C (genotype 1) – telaprevir. NICE technology appraisal 252 (2012)

Tuberculosis – hard-to-reach groups. NICE public health guidance 37 (2012)

Increasing the uptake of HIV testing among men who have sex with men. NICE public health guidance 34 (2011)

Increasing the uptake of HIV testing among black Africans in England. NICE public health guidance 33 (2011)

Looked-after children and young people. NICE public health guidance 28 (2011)

Hepatitis C – peginterferon alfa and ribavirin. NICE technology appraisal 200 (2010)

Hepatitis B – tenofovir disoproxil fumarate. NICE technology appraisal 173 (2009)

Reducing differences in the uptake of immunisations. NICE public health guidance 21 (2009)

Needle and syringe programmes. NICE public health guidance 18 (2009)

Community engagement. NICE public health guidance 9 (2008)

Antenatal care. NICE clinical guideline 62 (2008)

Hepatitis B – telbivudine. NICE technology appraisal 154 (2008)

Hepatitis B – entecavir. NICE technology appraisal 153 (2008)

Prevention of sexually transmitted infections and under-18 conceptions. NICE public health guidance 3 (2007)

Hepatitis C – peginterferon alfa and ribavirin. NICE technology appraisal 106 (2006)

Hepatitis B (chronic) – adefovir dipivoxil and pegylated interferon alpha-2a. NICE technology appraisal 96 (2006)

Hepatitis C – pegylated interferons, ribavirin and alfa interferon. NICE technology appraisal 75 (2004)

Under development

Hepatitis B: diagnosis and management. NICE clinical guideline (publication expected June 2013)

Hepatitis C (children and young people) – peginterferon alfa and ribavirin. NICE technology appraisal (publication expected August 2013)

Hepatitis C. NICE clinical guideline (publication date to be confirmed)

  • National Institute for Health and Care Excellence (NICE)